Table of Contents List of Tables List of Figures Introduction Global Markets Direct Report Coverage West Nile Virus Infections - Overview West Nile Virus Infections - Therapeutics Development Pipeline Overview Pipeline by Companies Pipeline by Universities/Institutes Products under Development by Companies Products under Development by Universities/Institutes West Nile Virus Infections - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type West Nile Virus Infections - Companies Involved in Therapeutics Development CEL-SCI Corp Ennaid Therapeutics LLC Hawaii Biotech Inc Hemispherx Biopharma Inc Kineta Inc Ology Bioservices Inc Plex Pharmaceuticals Inc West Nile Virus Infections - Drug Profiles AGS-v - Drug Profile Product Description Mechanism Of Action R&D Progress Alferon LDO - Drug Profile Product Description Mechanism Of Action R&D Progress BG-323 - Drug Profile Product Description Mechanism Of Action R&D Progress Bispecific Monoclonal Antibody for West Nile Virus Infections - Drug Profile Product Description Mechanism Of Action R&D Progress CEL-1000 - Drug Profile Product Description Mechanism Of Action R&D Progress ETX-112 - Drug Profile Product Description Mechanism Of Action R&D Progress HBV-002 - Drug Profile Product Description Mechanism Of Action R&D Progress HydroVax-001 - Drug Profile Product Description Mechanism Of Action R&D Progress interferon alfa-n3 - Drug Profile Product Description Mechanism Of Action R&D Progress KIN-1148 - Drug Profile Product Description Mechanism Of Action R&D Progress KIN-1400 - Drug Profile Product Description Mechanism Of Action R&D Progress rintatolimod - Drug Profile Product Description Mechanism Of Action R&D Progress Small Molecule to Inhibit NS2B-NS3 Protease for Dengue, West Nile Virus and Zika Infections - Drug Profile Product Description Mechanism Of Action R&D Progress Small Molecules for Viral Infections - Drug Profile Product Description Mechanism Of Action R&D Progress Small Molecules to Inhibit NS5 for Japanese Encephalitis and Viral Infections - Drug Profile Product Description Mechanism Of Action R&D Progress Tatbeclin-1 - Drug Profile Product Description Mechanism Of Action R&D Progress West Nile virus vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress West Nile virus vaccine - Drug Profile Product Description Mechanism Of Action R&D Progress West Nile Virus Infections - Dormant Projects West Nile Virus Infections - Product Development Milestones Featured News & Press Releases Feb 21, 2017: hVIVO notes the initiation of a Phase I clinical trial with AGS-v, a mosquito-borne disease vaccine candidate Jul 06, 2015: NIH-funded vaccine for West Nile Virus enters human clinical trials May 05, 2014: Alferon N Effective Against MERS Virus In-Vitro Sep 12, 2013: Hemispherx Announces Initial Test Results in Biosecurity/Biodefense Arena Sep 06, 2011: Hemispherx Enters Into Strategic Alliance With Armada Health Care For Alferon N Injection Apr 20, 2010: Kineta Scientist to Present Novel Antiviral Research Findings at International Conference Appendix Methodology Coverage Secondary Research Primary Research Expert Panel Validation Contact Us Disclaimer

List of Tables Number of Products under Development for West Nile Virus Infections, H1 2018 Number of Products under Development by Companies, H1 2018 Number of Products under Development by Universities/Institutes, H1 2018 Products under Development by Companies, H1 2018 Products under Development by Universities/Institutes, H1 2018 Number of Products by Stage and Target, H1 2018 Number of Products by Stage and Mechanism of Action, H1 2018 Number of Products by Stage and Route of Administration, H1 2018 Number of Products by Stage and Molecule Type, H1 2018 West Nile Virus Infections - Pipeline by CEL-SCI Corp, H1 2018 West Nile Virus Infections - Pipeline by Ennaid Therapeutics LLC, H1 2018 West Nile Virus Infections - Pipeline by Hawaii Biotech Inc, H1 2018 West Nile Virus Infections - Pipeline by Hemispherx Biopharma Inc, H1 2018 West Nile Virus Infections - Pipeline by Kineta Inc, H1 2018 West Nile Virus Infections - Pipeline by Ology Bioservices Inc, H1 2018 West Nile Virus Infections - Pipeline by Plex Pharmaceuticals Inc, H1 2018 West Nile Virus Infections - Dormant Projects, H1 2018 West Nile Virus Infections - Dormant Projects, H1 2018 (Contd..1), H1 2018List of Figures Number of Products under Development for West Nile Virus Infections, H1 2018 Number of Products under Development by Companies, H1 2018 Number of Products under Development by Universities/Institutes, H1 2018 Number of Products by Targets, H1 2018 Number of Products by Stage and Targets, H1 2018 Number of Products by Mechanism of Actions, H1 2018 Number of Products by Stage and Mechanism of Actions, H1 2018 Number of Products by Routes of Administration, H1 2018 Number of Products by Stage and Routes of Administration, H1 2018 Number of Products by Molecule Types, H1 2018 Number of Products by Stage and Molecule Types, H1 2018